CA9 and breast carcinoma: In vitro investigations have demonstrated that inhibition of CAIX using siRNA or CAIX inhibitors decreased the invasiveness of renal and ovarian cancer cells, while also reducing the amount of cells invading from human breast carcinoma spheroids [40,66,69,70].